10.2337/dc15-2336 [DOI] [PubMed] 105.Rowlands A, Davies M, Dempsey P, Edwardson C, Razieh C, Yates T
It is also used to manage type 2 diabetes
In clinical trials of ZEPBOUND, cholelithiasis was reported in 1.1% of ZEPBOUND-treated patients and 1% of placebo-treated patients, cholecystitis was reported in 0.7% of ZEPBOUND-treated patients and 0.2% of placebo-treated patients, and cholecystectomy was reported in 0.2% of ZEPBOUND-treated patients and no placebo-treated patients
Transcription profile analysis of chlorophyll biosynthesis in leaves of wild-type and chlorophyll b-deficient rice ( Oryza sativa L.)
Always consult a healthcare provider before starting new supplements to ensure safety and avoid interactions
Patients should immediately go to the hospital if they experience unremitting symptoms, severe dehydration, or difficulty maintaining consciousness